Δ9-tetrahydrocannabinol, a cannabis sativa–derived natural product, as a probe of endocannabinoid system plasticity in type 1 diabetes: a receptor-level, testable hypothesis
Type 1 diabetes (T1D) is a chronic autoimmune disease in which receptor-level regulation of the endocannabinoid system (ECS) remains largely unmapped. While ECS perturbations have been extensively described in obesity and type 2 diabetes, a directed experimental interrogation of receptor adaptabilit...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-07-01
|
| Serier: | Frontiers in Natural Products |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fntpr.2026.1812441/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|